Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.

Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients

NCT07052734 ·Status: COMPLETED

Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer

NCT04720508 ·Status: UNKNOWN

Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions

NCT05510037 ·Status: COMPLETED

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

NCT04365790 ·Status: UNKNOWN

Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

NCT04247035 ·Status: UNKNOWN

LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis

NCT06427720 ·Status: COMPLETED

Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype

NCT06813456 ·Status: RECRUITING

A Composite Assay for HER2-positive Early-stage Breast Cancer Management

NCT06762977 ·Status: RECRUITING

Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil

NCT05034393 ·Status: COMPLETED

Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

NCT07093775 ·Status: NOT_YET_RECRUITING

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

NCT02662868 ·Status: COMPLETED

HER2-positive Breast Cancer Registry

NCT06603597 ·Status: RECRUITING

TME Alteration in HER2 Positive Breast Cancer

NCT06533670 ·Status: ACTIVE_NOT_RECRUITING

Discordant HER2/Neu Status of Breast Cancer.

NCT01935739 ·Status: COMPLETED

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

NCT05754047 ·Status: COMPLETED

Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer

NCT06868758 ·Status: ACTIVE_NOT_RECRUITING

microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin

NCT02656589 ·Status: UNKNOWN

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

NCT06149377 ·Status: COMPLETED

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING

Shear-wave Elastography in Breast Cancer

NCT06123819 ·Status: NOT_YET_RECRUITING

Recurrence Risk Evaluation by 21-gene Detection

NCT03841266 ·Status: COMPLETED

Omission of Radiation in Patients With Her-2 Positive Breast Cancer

NCT03460067 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

NCT06102018 ·Status: RECRUITING

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

NCT06518382 ·Status: RECRUITING

Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer

NCT06833502 ·Status: RECRUITING ·Phase: PHASE2